AVANGRID (AGR) PT Lowered to $34 at BofA Securities
Tweet
Share
E-mailGet Alerts AGR Hot Sheet
Price: $36.02 --0%
Rating Summary:
3 Buy, 9 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 20
Rating Summary:
3 Buy, 9 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 20
Join SI Premium – FREE
BofA Securities analyst Paul Zimbardo lowered the price target on AVANGRID (NYSE: AGR) to $34.00 (from $37.00) while maintaining a Underperform rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Edgewise Therapeutics (EWTX) PT Raised to $60 at JPMorgan
- CrowdStrike (CRWD) PT Raised to $235 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
